Skip to product information
These high-rise leggings feel like a second skin—lightweight, super-stretchy, and whisper-soft against your skin. The sculpting cross-front waistband sits flattering and secure, moving with you through morning flows, errands, or evening walks. Made from a durable, eco-conscious blend of 70% recycled nylon and 30% elastane, they balance performance and planet-friendly design. A small, colorful side print adds playful personality without shouting, so you can blend function and style whether you’re headed to a studio class or lounging at home. Pairs easily with the matching Women's Luxe Bra for a cohesive look.
Product features
- 70% recycled nylon, 30% elastane — sustainable performance
- Ultra-soft, second-skin fabric for all-day comfort
- High-rise with contoured cross-front waistband for a flattering fit
- Super-stretch construction that moves with you
- Made from blanks sourced in Kenya; matches Women's Luxe Bra
Care instructions
- Machine wash: cold (max 30C or 90F), gentle cycle
- Do not dryclean
- Iron, steam or dry: low heat, do not iron on print
- Do not tumble dry
- Do not bleach
Syrup Leggings
$46.00 USD
Sale price
$46.00 USD
Regular price
★ 100% of profit funds diabetes research · Free returns · Ships in 2–5 business days
Details & materials
Product features
- 70% recycled nylon, 30% elastane — sustainable performance
- Ultra-soft, second-skin fabric for all-day comfort
- High-rise with contoured cross-front waistband for a flattering fit
- Super-stretch construction that moves with you
- Made from blanks sourced in Kenya; matches Women's Luxe Bra
Care instructions
- Machine wash: cold (max 30C or 90F), gentle cycle
- Do not dryclean
- Iron, steam or dry: low heat, do not iron on print
- Do not tumble dry
- Do not bleach
Shipping & returns
Printed and shipped from the US. Orders leave the shop in 2–5 business days, then 3–5 days in transit.
Something not right? Email joshua@chubrun.com within 30 days and we'll make it right.
Where your money goes
100% of profit from every order funds diabetes research. We're working to cure it, not just manage it. Read more →